What is the recommended dose of cinnarizine (Cinnarizine) for an 8-year-old child weighing 25 kilograms (kg) for motion sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cinnarizine Dosage for Motion Sickness in an 8-Year-Old Child

The recommended dose of cinnarizine for an 8-year-old child weighing 25 kg for motion sickness is 12.5 mg (half of a 25 mg tablet), given up to three times daily as needed. This dosage balances efficacy against motion sickness with safety considerations in pediatric patients.

Dosing Recommendations

  • For children weighing 25 kg (like an average 8-year-old), the appropriate dose is 12.5 mg per administration 1
  • Maximum daily dose should not exceed 37.5 mg (12.5 mg three times daily) 2
  • First dose should be given 1-2 hours before travel to allow sufficient time for the medication to take effect 3
  • Subsequent doses can be given every 6-8 hours as needed for continued protection 1

Pharmacological Considerations

  • Cinnarizine is a first-generation antihistamine with antihistaminic, antiserotoninergic, and calcium channel-blocking properties 2
  • It is effective for prevention of motion sickness symptoms under natural conditions compared to placebo (40% vs 25% prevention rate) 1
  • The elimination half-life in children has been reported as approximately 3.65 hours, which supports the multiple daily dosing schedule 2

Safety Considerations

  • Monitor for common side effects, which may include:

    • Drowsiness/sedation (more likely than with placebo) 1
    • Potential for jitteriness or altered gait at higher doses 2
    • Potential for central nervous system effects 5-7 hours post-administration 4
  • Avoid doses exceeding the recommended amount, as overdose can lead to:

    • Increased sedation
    • Neurological symptoms including stupor
    • In rare cases with significant overdose, seizures have been reported 2

Administration Tips

  • Cinnarizine can be administered with or without food, but giving with food may reduce gastrointestinal side effects 3
  • For children who cannot swallow tablets, the tablet may be crushed and mixed with a small amount of food or liquid 1
  • If motion sickness symptoms are severe, the first dose should ideally be given 2 hours before travel 4

Monitoring

  • Observe for excessive drowsiness, which may indicate the need for dose reduction 5
  • If drowsiness interferes with activities, consider reducing to 6.25 mg (quarter tablet) per dose 1
  • If the child experiences any unusual neurological symptoms such as tremor or abnormal movements, discontinue the medication and seek medical attention 2

Important Caveats

  • Cinnarizine may cause increased drowsiness when combined with other sedating medications 5
  • Effects on performance and alertness may persist for 5-7 hours after administration 4
  • The medication should be used for short-term management of motion sickness rather than continuous long-term use 1

References

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Research

Cinnarizine for Sea Sickness During a Remote Pacific Ocean Rescue Mission.

Journal of special operations medicine : a peer reviewed journal for SOF medical professionals, 2015

Research

Time-course of effects of oral cinnarizine and hyoscine on task performance.

Journal of psychopharmacology (Oxford, England), 1989

Research

Central effects of cinnarizine: restricted use in aircrew.

Aviation, space, and environmental medicine, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.